{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:23:49Z","timestamp":1769016229161,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.amjcard.2004.04.059","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T18:24:01Z","timestamp":1093631041000},"page":"443-447","source":"Crossref","is-referenced-by-count":25,"title":["Usefulness of spironolactone in a specialized heart failure clinic"],"prefix":"10.1016","volume":"94","author":[{"given":"Wendy","family":"Sligl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finlay A.","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2004.04.059_BIB1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0735-1097(02)02694-3","article-title":"Complications of inappropriate use of spironolactone in heart failure","volume":"41","author":"Bozkurt","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9343(01)00642-8","article-title":"Life threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone","volume":"110","author":"Schepkens","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0002-9149(02)02580-8","article-title":"Estimation of glomerular filtration rate to prevent life-threatening hyperkalemia due to combined therapy with spironolactone and angiotensin-converting enzyme inhibition or angiotensin receptor blockade","volume":"90","author":"Blaustein","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9149(02)02581-X","article-title":"Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease","volume":"90","author":"Obailo","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/ndt\/gfg295","article-title":"Hyperkalemia in congestive heart failure patients using ACE inhibitors and spironolactone","volume":"18","author":"Cruz","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.327.7407.147","article-title":"Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers","volume":"327","author":"Wrenger","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0140-6736(05)72606-4","article-title":"Spironolactone and congestive heart failure","volume":"355","author":"Georges","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB9","first-page":"111","article-title":"Spironolactone prescribing in heart failure","volume":"70","author":"McMullan","year":"2001","journal-title":"Ulster Med J"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB10","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1136\/heart.85.4.e8","article-title":"Serious adverse events experienced by patients with chronic heart failure taking spironolactone","volume":"85","author":"Berry","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)73234-7","article-title":"Early uptake of research findings after fast-track publication","volume":"355","author":"Ghali","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.164.7.769","article-title":"The use of beta-blockers in a tertiary care heart failure clinic. Dosing, tolerance, and outcomes","volume":"164","author":"Tandon","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7326\/0003-4819-138-11-200306030-00016","article-title":"Applying evidence to patient care","volume":"138","author":"McAlister","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9343(02)01346-3","article-title":"The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with congestive heart failure","volume":"113","author":"Sin","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB17","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJM200006223422511","article-title":"Randomized trials or observational tribulations?","volume":"342","author":"Pocock","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB18","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","article-title":"A comparison of observational studies and randomized, controlled trials","volume":"342","author":"Benson","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB19","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.04.059_BIB20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0002-9343(00)00743-9","article-title":"A systematic review of randomized trials of disease management programs in congestive heart failure","volume":"110","author":"McAlister","year":"2001","journal-title":"Am J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904007064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904007064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T15:26:01Z","timestamp":1549293961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914904007064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0002914904007064"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2004.04.059","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}